Alpha DNA Investment Management’s Dover DOV Stock Holding History

Alpha DNA Investment Management’s Portfolio DOV Stock Details DOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41	Closed	-$5K	–	245
2021 Q1	$5K	Buy	+41	New	+$5.22K	0.01%	358

Other funds holding DOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Alpha DNA Investment Management's DOV Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Dover (DOV) in Q2 2021, closing a stake of 41 shares — an estimated $5K sold.

Alpha DNA Investment Management first reported a position in DOV in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 835 funds tracked by Wall St. Rank hold DOV as of Q2 2021.

Alpha DNA Investment Management reported no remaining Dover position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 41 Dover shares in Q2 2021, an estimated $5K.
Alpha DNA Investment Management first reported a position in Dover in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Dover position peaked at $5K in Q1 2021.
835 funds tracked by Wall St. Rank held Dover as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.